Order reprints

Open Access Highly Accessed

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

Peter Matthews*, Marc Alpert, Galia Rahav, Denise Rill, Edward Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C McGovern and , for the Tigecycline 900 cSSSI Study Group

BMC Infectious Diseases 2012, 12:297  doi:10.1186/1471-2334-12-297

This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.

Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.

Fields marked * are required

http://www.biomedcentral.com/1471-2334/12/297
1471-2334-12-297